About DexTech

Dextech Medical AB was founded in 2004 by Anders R Holmberg, PhD. and chemical engineer, as well as CEO of the company and Sten Nilsson, physician and professor of oncology.

DexTech develops drug candidates with applications in urological oncology, primarily prostate cancer. The company has a strong clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology. Research and development is conducted cost-effectively through collaborations through a global network.